Switzerland ranks among world leaders for trademark and patent filings
A record number of international patents were filed last year despite the Covid-19 pandemic. Switzerland was ranked eighth place in annual patent rankings published by the United Nations World Intellectual Property Organisation (WIPO).
This content was published on
2 minutes
swissinfo.ch/RTS/AFP/sb
Español
es
Suiza es uno de los líderes mundiales en introducción de marcas y patentes
A record 277,500 international patents were filed in 2021 – a 0.9% increase from 2020, the Geneva-based WIPO reportedExternal link on Thursday.
Asia accounted for most international patent applications (54.1%), with China holding the top spot with 69,540 filings. The US remained in second place last year, with 59,570 filings, followed by Japan (50,260), South Korea (20,678) and Germany (17,322).
Switzerland stayed in eighth spot, but the total number of patents filed (5,386) was up by 6% compared with 2020.
For the fifth consecutive year, China-based telecoms giant Huawei Technologies topped the table, with 6,952 patent applications. It was followed by US firm Qualcomm (3,931), South Korea’s Samsung Electronics (3,041) and LG Electronics (2,855) and Mitsubishi Electric Corp of Japan (2,673).
Computer technology accounted for the largest share of patent applications, followed by digital communication and medical technology. The pharmaceutical field recorded the strongest growth for filings (+12.8%), followed by biotechnology (+9.5%).
Swiss pharma giant Novartis slipped from first to fifth place for the number of international trademark applications (94) registered in 2021. Oréal of France topped the ranking, followed by ADP Gauselmann, the Glaxo Group and Huawei Technologies. Switzerland registered a total of 3,832 international trademarks last year, putting it in sixth spot overall.
More
More
Genome editing’s patent problem fuels concern for the future of food
This content was published on
Genome editing is touted as a solution to feeding a planet battered by climate change. But an outdated patent system could stifle its potential.
Swiss price watchdog slams excessive prices for generic medicines
This content was published on
The cheapest generic medicines available in Switzerland are more than twice as expensive as in other countries, according to a study by the Swiss price watchdog.
Nature should not figure in net zero calculations: academic study
This content was published on
The natural removal of CO2 from the atmosphere by forests or oceans should not be included in the net-zero balance of climate protection measures, argue researchers.
This content was published on
None of the 15 major Swiss retail banks is meeting international climate and biodiversity targets, according to a ranking by WWF Switzerland.
This content was published on
Nestlé's new CEO Laurent Freixe, has presented plans for the future of the world's largest food company, after his first few weeks in office.
Swiss foreign minister calls on Moscow to end Ukraine war
This content was published on
It's high time Moscow ended its war against Ukraine, Swiss foreign minister Ignazio Cassis tells the UN Security Council.
This content was published on
The only alternative to the UN Palestinian agency’s work in Gaza is to allow Israel to run services there, Philippe Lazzarini, UNRWA Commissioner-General, told reporters in Geneva on Monday.
Study reveals food culture differences between Switzerland and neighbours
This content was published on
Three-quarters of Swiss people consider eating to be a pleasurable, social activity, a new survey reveals. Healthy eating, however, plays a much less important role, it found.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Genome editing’s patent problem fuels concern for the future of food
This content was published on
Genome editing is touted as a solution to feeding a planet battered by climate change. But an outdated patent system could stifle its potential.
Swiss open to compromise in Covid vaccine talks at WTO
This content was published on
Switzerland is open to compromise in talks on the IP rights of Covid-19 vaccines and drugs at the World Trade Organization.
Global corporate tax deal reshapes how Switzerland attracts multinationals
This content was published on
The global corporate tax deal endorsed by the G20 won’t end tax competition but it will look different. This plays to Switzerland’s advantages.
Legal victory for Lindt in German chocolate bunny case
This content was published on
The Federal Court of Justice delivered its verdict on Thursday in a battle between Lindt and German company Heilemann, which in 2018 also marketed a chocolate bunny in a gold foil wrap. Lindt claimed it had a trademark on the colour, acquired by use, and that Heilemann had infringed this trademark and should be prevented…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.